Company News
Unlocking the Black Box: Mechanisms of Resistance in Next-Generation Antibody-Drug Conjugates
India Reports Nipah Virus Outbreak: What is Nipah Virus?
Alpha Lifetech has established a mature and robust Antibody Discovery Platform to accelerate drug discovery pipeline.
Literature Analysis (IF 10.3) | A Deep Dive into Phage Display-Driven Antibody Engineering
Alpha Lifetech’s Antibody Discovery services delivering highly specific VHH, scFv and Fab antibodies with superior affinity by Phage Display Technology.
Literature Analysis (IF 45.8) | Relationship Between CAR-T Therapy and Bispecific Antibodies
Alpha Lifetech has extensive expertise in peptide library construction and screening services. In addition to our existing peptide libraries, we offer peptide library design and screening services.
Literature Analysis (IF 13.7) | AI-Powered Precision Design of Macrocyclic Peptides: Cracking the Code of "Undruggable" Targets
Leveraging established core platforms for recombinant protein expression and antibody discovery, Alpha Lifetech efficiently supports the requirements for target protein preparation and production.
Literature Analysis (IF 19.9) | VHH: The Next-Generation Biologic for Unlocking Brain Disease Therapies
VHH, thanks to their unique small size and high penetrability, overcome the limitations of the blood-brain barrier, thus ushering in breakthroughs for the treatment of brain diseases.
Literature Analysis (BioRxiv) | Advancing Protein Design: Insights into RFdiffusion3
This article provides an in-depth overview of RFdiffusion3, a state-of-the-art diffusion model from Nobel laureate David Baker's team, highlighting its atomic-level innovations for designing proteins.
Literature Analysis (IF 41.7) | Cas9-EDV: An Innovative Platform for Precise In Vivo Cell Editing
The US-based Hamilton team has developed a novel Cas9-EDV delivery system, achieving precise in vivo editing of human T cells for the first time and paving a safe and efficient new path for gene therapy.
TREG and FOXP3: An Interpretation of the 2025 Nobel Prize in Physiology or Medicine
The 2025 Nobel Prize in Physiology or Medicine has been awarded to three immunologists for their pioneering discoveries concerning the mechanism of peripheral immune tolerance. The laureates are Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi.
Phage Display Technology: Market Prospects and Research Advances
Phage Display Technology: Market Prospect Analysis And Research Progress